Pharmaceutical Effects of Trans-Cinnamaldehyde Nanoparticles on Cancer Types
Özet Görüntüleme: 498
/ 
PDF İndirme: 328
DOI:
https://doi.org/10.5281/zenodo.17101783Anahtar Kelimeler:
Cancer, Nanoparticles, Cell LineÖzet
Cancer research has been intensively ongoing for years, particularly in the field of treatment. Despite the development of numerous chemotherapeutic agents, a definitive cure has yet to be achieved. One of the major obstacles in treatment is the tumor microenvironment, which plays a critical role in cancer progression and therapy resistance. This microenvironment facilitates metastasis to healthy tissues and contributes to the development of multidrug resistance (MDR) against existing chemotherapeutic agents. Therefore, developing nanotechnological chemotherapeutic agents capable of bypassing the tumor microenvironment while minimizing systemic side effects is of great importance. Studies on the biological activities of cinnamaldehyde are quite popular. This review focuses on cinnamaldehyde-loaded nanoparticles used in cancer studies.
Referanslar
Bilici E, Akkoç S, Investigation of the Cytotoxic Effect of A New NPhenyl Benzimidazole Derivative on Cell Viability in A549 and HepG2 Cell Lines, 2025, Van Med J 32 (1): 3-6.
Bukowski K, Kciuk M, Kontek R. Mechanisms of Multidrug Resistance in Cancer Chemotherapy. Int J Mol Sci. 2020 May 2;21(9):3233.
Duan C, Yu M, Xu J, Li BY, Zhao Y, Kankala RK. Overcoming Cancer Multi-drug Resistance (MDR): Reasons, mechanisms, nanotherapeutic solutions, and challenges. Biomedicine & Pharmacotherapy. 2023 Jun;162:114643.
Peng J, Song X, Yu W, Pan Y, Zhang Y, Jian H, et al. The role and mechanism of cinnamaldehyde in cancer. J Food Drug Anal. 2024 Jun 10;32(2):146–60.
Wei G, Wang Y, Yang G, Wang Y, Ju R. Recent progress in nanomedicine for enhanced cancer chemotherapy. Theranostics. 2021;11(13):6370–92.
Awasthi R, Roseblade A, Hansbro PM, Rathbone MJ, Dua K, Bebawy M. Nanoparticles in Cancer Treatment: Opportunities and Obstacles. Curr Drug Targets. 2018 Sep 27;19(14):1696–709.
Cho K, Wang X, Nie S, Chen Z (Georgia), Shin DM. Therapeutic Nanoparticles for Drug Delivery in Cancer. Clinical Cancer Research. 2008 Mar 1;14(5):1310–6.
Banerjee S, Anticancer Potential and Molecular Mechanisms of Cinnamaldehyde and Its Congeners Present in the Cinnamon Plant. Physiologia. 2023 Mar 30;3(2):173–207.
Liakos IL, Menager C, Guigo N, Holban AM, Iordache F, Pignatelli F, et al. Suberin/ trans- Cinnamaldehyde Oil Nanoparticles with Antimicrobial Activity and Anticancer Properties When Loaded with Paclitaxel. ACS Appl Bio Mater. 2019 Aug 19;2(8):3484–97.
Zhou Z, Wang C, Bai J, Zeng Z, Yang X, Wei B, et al. Cinnamaldehyde-modified chitosan hybrid nanoparticles for DOX delivering to produce synergistic anti-tumor effects. Front Bioeng Biotechnol. 2022;10:968065.
Barrera-Martínez CL, Meléndez-Ortiz HI, Padilla-Vaca F, Atanase LI, Peralta-Rodríguez RD, Liakos I. Dual Loading of Trans-Cinnamaldehyde and Either Paclitaxel or Curcumin in Chitosan Nanoparticles: Physicochemical Characterization and Biological Evaluation Against MDCK and HeLa Cells. Polymers (Basel). 2024 Oct 31;16(21):3087.
Bilici E, Türkoğlu BG, Akkoç S (2025). Using the MTT Cell Viability Test and Immunocytochemistry Techniques, Benzimidazole's Cytotoxicity and Apoptosis Activation in Mouse 4T1 Cell Culture. Dicle Univ Vet Fak Derg., 18(1):33-37.
Song W, Zeng J, Ji P, Han Z, Sun Y, Zhang X. Self‐Assembled Copper‐Based Nanoparticles for Glutathione Activated and Enzymatic Cascade‐Enhanced Ferroptosis and Immunotherapy in Cancer Treatment. Small. 2023 Aug 28;19(35).
Huang C, Ding S, Jiang W, Wang FB. Glutathione-depleting nanoplatelets for enhanced sonodynamic cancer therapy. Nanoscale. 2021;13(8):4512–8.
Wu H, Zhang Z, Cao Y, Hu Y, Li Y, Zhang L, et al. A Self-Amplifying ROS-Responsive Nanoplatform for Simultaneous Cuproptosis and Cancer Immunotherapy. Adv Sci (Weinh). 2024 Jun;11(23):e2401047.
Jiang C, Li X, Wan S, Ji S, Wang Q, Hu S, et al. Copper‐Doped Polydopamine Nanoparticles‐Mediated GSH/GPX4‐Depleted Ferroptosis and Cuproptosis Sensitizes Lung Tumor to Checkpoint Blockade Immunotherapy. Small. 2025 Jun 15;21(23).
Zheng S, Li M, Xu W, Zhang J, Li G, Xiao H, et al. Dual-targeted nanoparticulate drug delivery systems for enhancing triple-negative breast cancer treatment. Journal of Controlled Release. 2024 Jul;371:371–85.
Chen Q, Jia C, Xu Y, Jiang Z, Hu T, Li C, et al. Dual-pH responsive chitosan nanoparticles for improving in vivo drugs delivery and chemoresistance in breast cancer. Carbohydr Polym. 2022 Aug;290:119518.
Dong K, Zhao ZZ, Kang J, Lin LR, Chen WT, Liu JX, et al. Cinnamaldehyde and Doxorubicin Co-Loaded Graphene Oxide Wrapped Mesoporous Silica Nanoparticles for Enhanced MCF-7 Cell Apoptosis. Int J Nanomedicine. 2020;15:10285–304.
Wang H, Lin S, Xie J, Chen X, Deng Y, Huang P, et al. Chondroitin sulfate nanoparticles based on co-delivery dual drug induced ferroptosis in lung cancer cells by disrupting mitochondrial oxidative homeostasis. Mater Today Bio. 2025 Apr;31:101632.
Wang Y, Wang Q, Wang X, Yao P, Dai Q, Qi X, et al. Docetaxel-loaded pH/ROS dual-responsive nanoparticles with self-supplied ROS for inhibiting metastasis and enhancing immunotherapy of breast cancer. J Nanobiotechnology. 2023 Aug 22;21(1):286.
Zhao C, Cao W, Zheng H, Xiao Z, Hu J, Yang L, et al. Acid-responsive nanoparticles as a novel oxidative stress-inducing anticancer therapeutic agent for colon cancer. Int J Nanomedicine. 2019;14:1597–618.
Yao P, Wang X, Wang Q, Dai Q, Peng Y, Yuan Q, et al. Cyclic RGD-Functionalized pH/ROS Dual-Responsive Nanoparticle for Targeted Breast Cancer Therapy. Pharmaceutics. 2023 Jun 26;15(7):1827.
Liu K, Jiao B, Zhang G, Gan Z, Lai S, Ding Z, et al. Self-enhanced ROS-responsive camptothecin prodrug nanoparticles elicit safe and efficient intravesical instillation therapy of bladder cancer. Journal of Controlled Release. 2025 Aug;384:113905.
He J, Ouyang S, Chen X, Xie C. Copper‐Containing Mesoporous Bioactive Glass Nanoparticles: A Novel Radiosensitizer for Nonsmall Cell Lung Cancer. Adv Nanobiomed Res. 2025 Aug 27.
İndir
Yayınlanmış
Nasıl Atıf Yapılır
Sayı
Bölüm
Lisans
Telif Hakkı (c) 2025 Euroasia Matematik, Mühendislik, Doğa ve Tıp Bilimleri Dergisi Medical Sciences
Bu çalışma Creative Commons Attribution-NonCommercial 4.0 International License ile lisanslanmıştır.
Dergimizde yayımlanan makaleler, 